$ADMA
ADMA Biologics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$9.11
▲+1.79%+$0.160
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateADMA Biologics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ADMA up today? It is at $9.11 (+1.79%), and our scanner flagged it 65 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ADMA spikes, and full due diligence on ADMA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ADMA 65 times in the last 30 days. Create a free account to track $ADMA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ADMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filingSC 13GPassive 5%+ stake disclosedAug 7, 2026 · 44 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kestenberg-Messina Kaitlin M. Officer | Sold (automatic/other) | -3K | sold 0.7% | 443K | $27K at $8.37 | Jul 24, 26 |
Kohler Terry Officer | Acquired (grant/award) | +85K 0.04% of company | added 100% | 143K | n/a | Jul 16, 26 |
Grossman Jerrold B Director | Bought (open market) | +6K | added 1.2% | 520K | $51K at $7.91 | May 27, 26 |
Grossman Jerrold B Director | Bought (open market) | +13K | added 2.5% | 514K | $100K at $8.01 | May 12, 26 |
Grossman Jerrold B Director | Bought (open market) | +13K | added 2.6% | 501K | $100K at $8.01 | May 11, 26 |
Kestenberg-Messina Kaitlin M. Officer | Sold (automatic/other) | -20K | sold 4.4% | 446K | $185K at $9.11 | Apr 1, 26 |
Guiheen Lawrence P. Director | Sold (automatic/other) | -30K 0.01% of company | sold 22% | 106K | n/a | Mar 17, 26 |
Guiheen Lawrence P. Director | Acquired (grant/award) | +30K 0.01% of company | added 59% | 81K | n/a | Mar 17, 26 |
Grossman Adam S Officer | Sold (automatic/other) | -21K | sold 1.0% | 2.11M | $318K at $15.16 | Mar 16, 26 |
Grossman Adam S Officer | Other | 15K | added 0.7% | 2.13M | $81K at $5.40 | Mar 16, 26 |
Guiheen Lawrence P. Director | Other | 30K 0.01% of company | added 28% | 136K | $110K at $3.66 | Mar 13, 26 |
Kestenberg-Messina Kaitlin M. Officer | Sold (automatic/other) | -91K 0.04% of company | sold 16% | 467K | n/a | Mar 9, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ADMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ADMA last traded at $9.11, up 1.79% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
ADMA Biologics, Inc. (ADMA) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ADMA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ADMA 65 times in the last 30 days.
ADMA (ADMA Biologics, Inc.) trades on XNAS, with a market cap of about $2.04B in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ADMA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ADMA discussion
Sign in to ask a question or join the discussion.